Je selectiemandje is leeg.
Maak een selectie van ETF's die je wilt vergelijken.
Voeg een ETF toe door op "Vergelijk" te klikken op een ETF-profiel of door een ETF aan te vinken in de ETF-zoekfunctie.
ETF Actief beheerde strategie
TER
0,75% p.a.
Distributiebeleid
Accumulerend
Replicatie
Fysiek
Fondsgrootte
EUR 39 m
Startdatum
12 april 2024
Bedrijven
36
Advertisement
Beleggen in crypto brengt risico’s met zich mee. Crypto is zeer volatie en je kunt (een deel van) je inleg verliezen.
Overzicht
Beschrijving
De ARK Genomic Revolution UCITS ETF USD Accumulating is een actief beheerde ETF.
The ETF invests in companies from around the world that are expected to derive revenue from technological innovations in the genomic healthcare sector. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance).
Grafiek
Basis
Data
| Index | ARK Genomic Revolution |
| Investeringsfocus | Aandelen, Wereld, Gezondheidszorg |
| Fondsgrootte | EUR 39 m |
| Totale kostenratio (TER) | 0,75% p.a. |
| Replicatie | Fysiek (Volledige replicatie) |
| Juridische structuur | ETF |
| Strategierisico | Actief beheerd |
| Duurzaamheid | Yes |
| Valuta van het fonds | USD |
| Valutarisico | Valuta niet gedekt |
| Volatiliteit 1 jaar (in EUR) | 44,80% |
| Startdatum/Noteringsdatum | 12 april 2024 |
| Distributiebeleid | Accumulerend |
| Distributiefrequentie | - |
| Vestigingsplaats van het fonds | Ierland |
| Fondsaanbieder | ARK Invest International |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | Northern Trust International Fund Administration Services (Ireland) Limited |
| Beleggingsadviseur | |
| Bewaarbank | Northern Trust Fiduciary Services (Ireland) Limited |
| Revisiebedrijf | Deloitte Ireland LLP |
| Einde belastingjaar | 1 juni |
| Vertegenwoordiger van Zwitserland | 1741 Fund Solutions AG |
| Zwitserse uitbetalende instantie | Tellco AG |
| Duitsland | 30% belastingvermindering |
| Zwitserland | ESTV Reporting |
| Oostenrijk | Belastingrapportagefonds |
| UK | UK-rapportage |
| Indextype | - |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | No |
| Tegenpartij die effecten uitleent |
Vergelijkbare ETF
In dit gedeelte vind je informatie over andere ETF met een vergelijkbare beleggingsfocus als de ARK Genomic Revolution UCITS ETF USD Accumulating
Vergelijkbare ETF via beleggingsgidsen
Wat vind je van ons ETF-profiel? Here you'll find our Questionnaire.
Bedrijven
Hieronder vind je informatie over de samenstelling van de ARK Genomic Revolution UCITS ETF USD Accumulating
Top 10 holdings
Weging van top 10-holdings
van 36
54,84%
| CRISPR Therapeutics | 8,29% |
| Tempus AI, Inc. | 7,88% |
| Twist Bioscience | 6,06% |
| Personalis | 5,75% |
| Recursion Pharmaceuticals | 5,69% |
| Beam Therapeutics | 4,74% |
| Natera | 4,66% |
| Absci | 4,42% |
| Intellia Therapeutics | 3,86% |
| Ionis Pharmaceuticals | 3,49% |
Landen
| Verenigde Staten | 77,12% |
| Zwitserland | 8,29% |
| Duitsland | 1,46% |
| Verenigd Koninkrijk | 1,23% |
Sectoren
| Gezondheidszorg | 86,73% |
| Technologie | 1,37% |
| Anders | 11,90% |
Vanaf 29/10/2025
Prestaties
Rendementsoverzicht
| YTD | +7,79% |
| 1 maand | +0,20% |
| 3 maanden | +2,68% |
| 6 maanden | +23,57% |
| 1 jaar | +6,41% |
| 3 jaar | - |
| 5 jaar | - |
| Since inception | +10,18% |
| 2025 | +9,22% |
| 2024 | - |
| 2023 | - |
| 2022 | - |
Maandelijks rendement in een heat map
Risico
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risico-overzicht
| Volatiliteit 1 jaar | 44,80% |
| Volatiliteit 3 jaar | - |
| Volatiliteit 5 jaar | - |
| Rendement/Risico 1 jaar | 0,14 |
| Rendement/Risico 3 jaar | - |
| Rendement/Risico 5 jaar | - |
| Maximaal waardedaling 1 jaar | -41,54% |
| Maximaal waardedaling 3 jaar | - |
| Maximaal waardedaling 5 jaar | - |
| Maximaal waardedaling sinds aanvang | -41,54% |
Voortschrijdende volatiliteit over 1 jaar
Beurs
Beursnoteringen
| Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | AAKG | - - | - - | - |
| Borsa Italiana | EUR | ARKG | - - | - - | - |
| London Stock Exchange | GBX | ARCG | |||
| London Stock Exchange | USD | ARKG | |||
| SIX Swiss Exchange | CHF | ARKG | |||
| Xetra | EUR | AAKG |
Meer informatie
Nieuwste artikelen
Veelgestelde vragen
What is the name of -?
The name of - is ARK Genomic Revolution UCITS ETF USD Accumulating.
What is the ticker of ARK Genomic Revolution UCITS ETF USD Accumulating?
The primary ticker of ARK Genomic Revolution UCITS ETF USD Accumulating is -.
What is the ISIN of ARK Genomic Revolution UCITS ETF USD Accumulating?
The ISIN of ARK Genomic Revolution UCITS ETF USD Accumulating is IE000O5M6XO1.
What are the costs of ARK Genomic Revolution UCITS ETF USD Accumulating?
The total expense ratio (TER) of ARK Genomic Revolution UCITS ETF USD Accumulating amounts to 0,75% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is ARK Genomic Revolution UCITS ETF USD Accumulating paying dividends?
ARK Genomic Revolution UCITS ETF USD Accumulating is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of ARK Genomic Revolution UCITS ETF USD Accumulating?
The fund size of ARK Genomic Revolution UCITS ETF USD Accumulating is 39m Euro. See the following article for more information about the size of ETFs.
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.